Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Theravance Biopharma, Inc. (TBPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Sold 1,807 shares @ $9.47, valued at $17.1k
08/22/2023 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 15,804 shares @ $9.7, valued at $153.3k
08/22/2023 4 Sawaf Aziz (SVP & CFO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 7,114 shares @ $9.7, valued at $69k
08/22/2023 4 Grimaud Brett A. (SVP, GEN COUNSEL AND SECRETARY) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 8,912 shares @ $9.7, valued at $86.4k
08/22/2023 4 GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 10,461 shares @ $9.7, valued at $101.5k
08/22/2023 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 10,460 shares @ $9.7, valued at $101.5k
08/15/2023 4 GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Sold 2,322 shares @ $9.99, valued at $23.2k
07/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2023 4 GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Sold 2,322 shares @ $10.69, valued at $24.8k
06/12/2023 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Sold 1,790 shares @ $11.13, valued at $19.9k
05/23/2023 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 15,804 shares @ $11.21, valued at $177.2k
05/23/2023 4 Sawaf Aziz (SVP & CFO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 8,744 shares @ $11.21, valued at $98k
05/23/2023 4 Grimaud Brett A. (SVP, GEN COUNSEL AND SECRETARY) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 11,469 shares @ $11.21, valued at $128.6k
05/23/2023 4 GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 10,460 shares @ $11.21, valued at $117.3k
05/23/2023 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 5,567 shares @ $11.21, valued at $62.4k
05/17/2023 4 GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Sold 2,322 shares @ $11.26, valued at $26.1k
05/04/2023 4 PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 9,132 shares @ $0
Granted 22,044 options to buy @ $10.95, valued at $241.4k
05/04/2023 4 O'Connor Donal (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 9,132 shares @ $0
Granted 22,044 options to buy @ $10.95, valued at $241.4k
05/04/2023 4 MITCHELL DEAN J (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 9,132 shares @ $0
Granted 22,044 options to buy @ $10.95, valued at $241.4k
05/04/2023 4 MALKIEL BURTON G (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 9,132 shares @ $0
Granted 22,044 options to buy @ $10.95, valued at $241.4k
05/04/2023 4 GRAY SUSANNAH (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 9,132 shares @ $0
Granted 22,044 options to buy @ $10.95, valued at $241.4k
05/04/2023 4 BROSHY ERAN (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 9,132 shares @ $0
Granted 22,044 options to buy @ $10.95, valued at $241.4k
05/04/2023 4 Smaldone Alsup Laurie (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 9,132 shares @ $0
Granted 22,044 options to buy @ $10.95, valued at $241.4k
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/16/2023 4 GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Sold 2,323 shares @ $10.32, valued at $24k
03/13/2023 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Sold 4,000 shares @ $10.2, valued at $40.8k
03/08/2023 4 GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Sold 2,323 shares @ $10.05, valued at $23.3k
03/03/2023 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 330,000 shares @ $0
03/03/2023 4 Sawaf Aziz (SVP & CFO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 80,000 shares @ $0
03/03/2023 4 Grimaud Brett A. (SVP, GEN COUNSEL AND SECRETARY) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 75,000 shares @ $0
03/03/2023 4 GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 75,000 shares @ $0
03/03/2023 4 Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 75,000 shares @ $0
02/28/2023 4 GRAY SUSANNAH (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 10,131 shares @ $0
Granted 1,688 shares @ $0
Granted 28,000 options to buy @ $9.87, valued at $276.4k
Granted 4,666 options to buy @ $9.87, valued at $46.1k
02/22/2023 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 37,420 shares @ $10.44, valued at $390.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy